TCL Archive Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee November 16, 1979
TCL Archive “Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy February 5, 1993
TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014